Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov31510.25208/0042-4609-2017-93-3-21-31SHORT COMMUNICATIONКРАТКИЕ СООБЩЕНИЯEPIDEMIOLOGY OPPORTUNISTIC MYCOSESЭПИДЕМИОЛОГИЯ ОППОРТУНИСТИЧЕСКИХ МИКОЗОВShkarinV. V.ШкаринВ. В.
Russian Federation

10/1 Minin & Pozharsky sq., Nizhny Novgorod, 603005, Russia

д.м.н., профессор, член-корреспондент РАН, зав. кафедрой эпидемиологии ФГБОУ ВО НижГМА Минздрава России; 603005, г. Нижний Новгород, пл. Минина и Пожарского, д. 10/1

 

 

saperkinnv@mail.ruSaperkinN. V.СаперкинН. В.
Russian Federation

10/1 Minin & Pozharsky sq., Nizhny Novgorod, 603005, Russia

к.м.н., доцент кафедры эпидемиологии, зав. НИИ профилактической медицины ФГБОУ ВО НижГМА Минздрава России; 603005, г. Нижний Новгород, пл. Минина и Пожарского, д. 10/1

Nizhny Novgorod state medical academyФГБОУ ВО «Нижегородская государственная медицинская академия» минздрава России0906201793321310910201709102017Copyright ©; 2017, Shkarin V.V., Saperkin N.V.Copyright ©; 2017, Шкарин В.В., Саперкин Н.В.2017Shkarin V.V., Saperkin N.V.Шкарин В.В., Саперкин Н.В.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/315

The review touches upon a problem of coinfection caused by several important fungal infections (aspergillus, candida, pneumocystis, cryptococcus) and infectious or parasitic diseases. The authors also investigate epidemiologic determinants of such clinical forms of pathologic process. There are a lot of scientific gaps in the studying coinfections concerning mycosis and other infections. Physicians and infection control practitioners sometimes reveal such cases therefore complex characteristics of the coinfections is required.

В обзоре обсуждается возможность сочетанности некоторых микозов (аспергиллез, кандидозы, пневмоцистоз, криптококкоз) с возбудителями инфекционных и паразитарных болезней. Особое внимание уделено эпидемиологическим характеристикам указанных форм инфекционного процесса. Проблема сочетанности микозов в целом в настоящее время изучена недостаточно. Подобные клинические формы могут встречаться в практике врача-дерматовенеролога и эпидемиолога и требуют подробной характеристики.

aspergillosiscandidosiscryptococcosispneumocystosiscoinfectionаспергиллезкандидозкриптококкозпневмоцистозсочетанностькоинфекция1. Yurasov V. V., Filatov A. I., Filippenkova E. I. Revealing fungal sepsis and CMV-infection associated with HIV in the forensic practice. Problemy ekspertizy v medicine 2012; 124: 53—54. [Юрасов В. В., Филатов А. И., Филиппенкова Е.И. Случай диагностики грибкового сепсиса и цитомегаловирусной инфекции на фоне ВИЧ-инфекции в судебно-медицинской практике. Проблемы экспертизы в медицине 2012; 124: 53—54.]2. Arvanitis M., Mylonakis Е. Characteristics, clinical relevance, and the role of Echinocandins in fungal-bacterial interactions. Clin Infect Dis 2015; (61); S630—634.3. Barbedo L. S., Vaz C., Pais C. et al. Different scenarios for Candida parapsilosis fungaemia reveal high numbers of mixed C. parapsilosis and Candida orthopsilosis infections. J Med Microbiology 2015; (64); 7—17.4. Tati S., Davidow P., McCall et al. Candida glabrata binding to Candida albicans hyphae enables its development in oropharyngeal candidiasis. PLoS Pathogens 2016; 12(3): e1005522.5. Makarova N.Ju., Kravchenko A. V., Jurin O. G. et al. Etiology of fungal infections in people living with HIV and drug resistance of fungi to fluconazole. Epidemiologija i infekcionnye bolezni 2003; (2): 33—35 [Макарова Н. Ю., Кравченко А. В., Юрин О. Г. и др. Особенности этиологии грибковых инфекций у больных ВИЧ-инфекцией и лекарственная устойчивость выявленных грибковых патогенов к флюконазолу. Эпидемиология и инфекционные болезни 2003; (2): 33—35.]6. Fontalvo D. M., Jimenez Borre G., Gomez Camargo D. et al. Tuberculosis and pulmonary candidiasis co-infection present in a previously healthy patient. Colombia Medica (Cali, Colombia) 2016; (47): 105—108.7. Chen X.-H., Gao Y., Zhang Y. et al. Tuberculosis infection might increase the risk of invasive candidiasis in an immunocompetent patient Revista do Instituto de medicina tropical de Sao Paulo 2015; (57): 273—275.8. Takahashi Y., Nagata N., Shimbo T. et al. Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: lessons from an endoscopic study of 80,219 patients. PloS One 2015; (10): e0133589.9. Chen A., Shieh E., Brinkley S. et al. Candida esophagitis in a human immunodeficiency virus-1-positive elite controller with hepatitis C virus cirrhosis. Open Forum Infectious Diseases 2014; (1): ofu111.10. Grueva Е., Коvachev Е. Characteristics of vaginal ecosystem in endocervicitis chlamydialis. Akush Ginekol Sofiia 2016; (55); 3—13.11. Wu T., Cen L., Kaplan C. et al. Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum. J Dent Res 2015; (94): 1432—1438.12. Massarrat S., Saniee P., Siavoshi F. et al. The effect of Helicobacter pylori infection, aging, and consumption of proton pump inhibitor on fungal colonization in the stomach of dyspeptic patients. Frontiers in Microbiology 2016; (7): 801.13. Pammi M., Zhong D., Johnson Y.et al. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infectious Diseases 2014; (14): 390.14. Gurbanova E. V. The intestinal microbiocenosis and features of immune response in children infested with parasitoses. Detskie infekcii 2010; (9): 34—37. [Гурбанова Э. В. Микробиоценоз кишечника и особенности иммунного ответа у детей, больных паразитозами. Детские инфекции 2010; (9): 34—37.]15. Aleksandrova N. A., Zaslavskaja M. I., Vahromova M. V. Antibiosis of enterococci and candida in the vaginal biotope and in vitro. Medicinskij al’manah 2016; (5): 91—94. [Александрова Н. А., Заславская М.И., Вахромова М. В. Антагонистические взаимоотношения энтерококков с кандидами на уровне вагинального биотопа и в эксперименте in vitro. Медицинский альманах 2016; (5): 91—94.]16. Scheres N., Krom B. P. StaphylococcusCandida interaction models: antibiotic resistance testing and host interactions. Methods in Mol Biol 2016; (1356): 153—161.17. Reno J., Doshi S., Tunali A. K. et al. Epidemiology of methicillin-Resistant Staphylococcus aureus bloodstream coinfection among adults with candidemia in Atlanta, GA, 2008—2012. Infect Control Hosp Epidemiol 2015; 36(11): 1298—1304.18. Stoytschakova V. B. Medical mycology: guideline foe doctors. M: GEOTAR-Media 2008. [Стойчакова В. Б. Медицинская микология: руководство для врачей. М: ГЭОТАР-Медиа 2008].19. Ezhov A. V., Shutova N.Ju., Husainova L. F. et al. Invasive aspregillosis as a sign of superinfection associated with severe staphylococcal pneumonia. Klinitsist 2012; (2): 59—63. [Ежов А. В., Шутова Н.Ю., Хусаинова Л.Ф. и др. Инвазивный аспергиллез как проявление суперинфекции на фоне тяжелой стафилококковой пневмонии. Клиницист 2012; (2): 59—63.]20. Enoki E., Maenishi O., Chikugo T. et al. Coinfection of Aspergillus and Cryptococcus in post-tuberculosis pulmonary cavity. Pathol Inl 2012; 62(8): 574—576.21. Alshabani K., Haq A., Miyakawa R. et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Review of Respiratory Medicine 2015; 9(1): 89—96.22. Zhang D., Wang X., Lv J. et al. Treatment of a patient with severe hemorrhagic fever accompanied by infection with methicillinresistant Staphylococcus aureus, Acinetobacter baumannii, aspergillus and mucor: a case report. Int J Clin Pharmacol Ther 2015; 53(12): 1028—1034.23. Tigen E., Tigen K., Karaahmet T. et al. Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment. Exp Clin Transplantation 2009; 7(3): 168—172.24. Siu Y.-P., Leung K.-T., Tong M. et al. Fatal case of Aspergillus coinfection in a renal transplant recipient suffering from cytomegalovirus pneumonitis (Case Report). Nephrology 2005; 10(6): 619—622.25. Pandey P., Dixit A. K., Tanwar A. Pulmonary echinococcal cyst with a filamentous fungus co-infection. Ghana Medical J 2013; (47): 148—152.26. Aliyali M., Badali H., Shokohi T. et al. Coinfection of pulmonary hydatid cyst and aspergilloma: case report and systematic review. Mycopathologia 2016; 181(3—4): 255—265.27. Guo J., Sun Y., Man Y. et al. Coinfection of Strongyloides stercoralis and Aspergillus found in bronchoalveolar lavage fluid from a patient with stubborn pulmonary symptoms. J Thorac Disease 2015; 7(3): E43-6.28. Davis N. A., Islamova Zh.I., Parpieva N.N. et al. Enteric parasites in patients with tuberculosis: influence on the cytokine status and pulmonary aspergillosis. Medicinskaja parazitologija i parazitarnye bolezni 2016; (3); 29—33. [Да- вис Н. А., Исламова Ж. И., Парпиева Н. Н. и др. Кишечные паразиты у больных туберкулезом: влияние на интерлейкиновый статус и развитие аспергиллеза легких. Медицинская паразитология и паразитарные болезни 2016; (3); 29—33.]29. Petramfar P., Yousefian M., Ashraf M. H. et al. Meningoencephalitis with Aspergillus and mycobacterium tuberculosis in a renal transplant recipient. Exp Clin Transplantation 2011; 9(1): 68—71.30. Kaneko T., Milner D. A., Marty F.M. et al. Triple opportunistic pulmonary cavitary disease after cord blood transplantation. Transplant Infectious Disease 2014; 16(5): 818—821.31. Alonso-Sierra M., Calvo M., GonzálezLama Y. Nocardia and Aspergillus Coinfection in a Patient with Ulcerative Colitis during Golimumab Therapy. Journal of Crohn’s and Colitis 2016; 10(9): 1127—1128.32. Misra D. P., Parida J. R., Chowdhury A. C. et al. Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still’s disease receiving steroids and tacrolimus. Case Reports, 2014; (nov14 1), bcr2014207335- bcr2014207335.33. Guillouzouic A., Bemer P., Gay-Andrieu F. et al. Fatal coinfection with Legionella pneumophila serogroup 8 and Aspergillus fumigatus. Diagn Microbiol Infect Dis 2008; 60(2): 193—195.34. Torres-Damas W., Yumpo-Cárdenas D., Mota-Anaya [Coinfection of rhinocerebral mucormycosis and sinus aspergillosis]. Revista peruana de medicina experimental y salud publica 2015; 32(4): 813—817.35. Gupta V., Rajagopalan N., Patil M. et al. Aspergillus and mucormycosis presenting with normal chest X-ray in an immunocompromised host. BMJ Case Reports; 2014(apr09 1): bcr2014204022-bcr2014204022.36. Mahadevaiah A. H., Rajagopalan N., Patil M. Coinfection of pulmonary mucormycosis and aspergillosis presenting as bilateral vocal cord palsy. BMJ Case Reports 2013(aug20 1): bcr2013009615-bcr2013009615.37. Bergantim R., Rios E., Trigo F. et al. Invasive coinfection with Aspergillus and Mucor in a patient with acute myeloid leukemia. Clinical Drug Investigation 2013; (33): S51—5.38. Pozo-Laderas J.C., Pontes-Moreno A., RoblesArista J. C. et al. Infección fúngica invasiva mixta por Rhizomucor pusillus y Aspergillus niger en un paciente inmunocompetente. Revista Iberoamericana de Micología 2015; 32(1): 46—50.39. Vaidya D., Shah P. Coinfection by Aspergillus and Zygomycetes species in a case of acute rhinosinusitis. Case Reports in Otolaryngology 2011; (2): 1—5.40. Hayashi Y., Eguchi H., Toibana T. et al. Polymicrobial sclerokeratitis caused by Scedosporium apiospermum and Aspergillus cibarius. Cornea 2013; 33(8): 875—877.41. Hagen F. Autochthonous and Dormant Cryptococcus gattii Infections in Europe. Emerg Infect Dis 2012; (18): 1618—1624.42. Elinov N. P., Bosak I. A. Present and past of C. neoformans as an object for studying a potentially harmful human pathogen. Probl med. mikologii 2006; 8; 47—51. [Елинов Н. П., Босак И. А. Прошлое и настоящее Cryptococcus neoformans как объекта из- учения потенциально грозного патогена для человека. Пробл мед. микологии 2006; 8; 47—51.]43. Fillipova L. V., Frolova E. V. Cryptococcus neoformans and innate immunity. Zh. probl. med. mikol 2011; 13; 10—12. [Филли- пова Л. В., Фролова Е. В. Cryptococcus neoformans и врожденный иммунитет. Ж. пробл. мед. микол 2011; 13; 10—12.]44. Viviani M. A., Cogliati M., Esposto M. C. et al. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res 2006; 6(4): 614—619.45. Nielsen K., Cox G.M., Litvintseva A. P. et al. Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun 2005; (73): 4922—4933.46. Senior K. Do we need to pay more attention to cryptococci? The Lancet Infectious Diseases. Russian edition 2010; 1: 286—288.47. Charushina I. P., Zotova N. V. Clinical and morphologic characteristic of cryptococcosis in HIV-infection. Zhurn infektol 2012; 4: 65—70. [Чарушина И.П., Зотова Н. В. Клинико-мор- фологическая характеристика криптокок- коза при ВИЧ-инфекции. Журн инфектол 2012; 4: 65—70.]48. Javier B., Susana L., Santiago G. et al. Pulmonary coinfection by Pneumocystis jiroveci and Cryptococcus neoformans. Asia Pac J Tropical Biomed 2012; (2): 80—82.49. Le T., Hong Chau T. T., Kim Cuc N. T. et al. AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: A Therapeutic Dilemma in Resource‐Limited Settings. Clin Infect Dis 2010; (51): e65—e68.50. Edwards L.J., Price R. N., Krause V. L.et al. Detection of Mycobacterium leprae by PCR testing of sputa from a patient with pulmonary cryptococcus coinfection in Northern Australia. J Clin Microbiol 2014; (52): 3811—3812.51. Azulay R. D., Mendonça I. R., Santos C.M. et al. Cutaneous cryptococcosis associated with lepromatous leprosy. Int. J. Dermatol 2001; (40): 412—414.52. Furuta M., Obara A., Harada N. et al. Cryptococcus neoformans can be misidentified as a microsporidian: studies of lung lesions in leprosy patients. J. Protozool 1991; (38): 95S—96S.53. Samad I., Wang M. C. L., Chong V. H. Intracerebral coinfection with Burkholderia pseudomallei and Cryptococcus neoformans in a patient with systemic lupus erythematosus. Southeast Asia J Trop Med Public Health 2014; (45): 352—356.54. Huang C.-L., Chen C.-T., Wu S.-W. et al. Simultaneous coinfection with Cryptococcus neoformans and Mycobacterium tuberculosis in an adult. QJM 2014; (107): 223—224.55. Martinez-Longoria C. A., Rubio-Perez J.-E., Rodriguez F. Severe meningoencephalitis coinfection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus. Int J Infect Diseases 2015; (33): 106—108.56. Mete B., Saltoglu N., Vanli E. et al. Simultaneous cryptococcal and tuberculous meningitis in a patient with systemic lupus erythematosus. J Microbiol Immun Inf 2016; 49: 289—294.57. Nanda S. P., Kass I., Cohn M. et al. Coexistence of tuberculous and cryptococcal meningitis. Pediatrics 1957; 20: 45—52.58. Burrows B., Barclay W. R. Combined cryptococcal and tuberculous meningitis complicating reticulum cell sarcoma. Am Rev Tuberc 1958; 78: 760—768.59. Niyongabo T., Aubry P. Simultaneous association of tubercular meningitis and cryptococcal meningitis in an African with human immunodeficiency virus HIV positive serology. Med Trop 1992; 52: 179—181.60. Gómez-Aranda F., López-Domínguez J.M., Muñoz Málaga A. et al. Meningitis simultaneously due to. Clin Infect Dis 1993; 16: 588—589.61. Costa P., Luzzati R., Nicolato A. et al. Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom’s macroglobulinemia treated with fludarabine. Leuk Lymphoma 2001; 28: 617—620.62. Manfredi R., Calza L. Severe brain co-infection with. Int J Infect Dis 2008; 12: 438—441.63. Grados C. D., Balo Araújo S., Benítez Díaz R. et al. Meningitis simultaneously due to cryptococcus. Med Clin 2009; 133: 361—362.64. Van Tongeren L., Shaipanich T., Fleetham J. A. Coinfection with Cryptococcus gattii and Mycobacterium tuberculosis in an otherwise healthy 18-year-old woman. Canadian Respiratory Journal 2011; 18(4): e62—3.65. Ermak T. N. Pneumocyst pneumonia, pulmonary tuberculosis and its combination in patients infected with HIV. Epidemiologija i infekcionnye bolezni 2008; (3): 34—38. [Ермак Т. Н. Пневмоцистная пневмония, ту- беркулез легких и их сочетание у больных ВИЧ-инфекцией. Эпидемиология и инфек- ционные болезни 2008; (3): 34—38.]66. Özkoç S., Alpaydın A. Ö., Delibas¸ S. B. Їnterstisyel akciger hastalıgı zemininde gelis¸ en pneumocystis jirovecii pnömonisi. Turkiye Parazitol Derg 2015; (39): 66—69.67. Baumann S., Reinwald M., Haghi D. et al. Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge. Onkologie 2013; (36): 582—584.68. Samitova Je.R., Savenkova M. S., Ermak T. N. et al. Clinical and morphologic observation of child with congenital pneumocystosis. Detskie infekcii 2016; (2): 57—61. [Самитова Э. Р., Савенкова М. С., Ермак Т. Н. и др. Клинико-морфологическое наблюдение ребенка с врожденным пневмоцистозом. Детские инфекции 2016; (2): 57—61.]69. Karev V. E., Skripchenko N. V., Vahmina A. V. A death of the child with HIV associated with pneumocyst pneumonia. Zhurn infektol 2013; 5: 103—108. [Карев В. Е., Скрипченко Н. В., Вахмина А. В. Случай летального исхода у ребенка с ВИЧ-инфекцией и пневмоцистной пневмонией. Журн инфектол 2013; 5: 103—108.]